Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DIWL76
|
|||
| Drug Name |
PVSRIPO
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Glioblastoma of brain [ICD-11: 2A00.00; ICD-10: C71] | Phase 2 | [1] | |
| Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [2] | ||
| Company |
Istari Oncology
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04479241) PVSRIPO and Pembrolizumab in Patients With Recurrent Glioblastoma. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT04577807) LUMINOS-102: PVSRIPO With or Without Immune Checkpoint Blockade in Patients With Advanced PD-1 Refractory Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.